{Etokimab: A Deep Investigation into the 2022981-44-6 Antibody Etokimab, designated by the specific identifier 2022981-44-6, represents a groundbreaking protein currently subject to therapeutic evaluation. This medicinal agent, targeting inflammatory mediators, aims to regulate the host reaction in several disease conditions. Preliminary results s